Matthias Husmann Selected Research

Fatty Acids (Saturated Fatty Acids)

7/2008

Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Husmann Research Topics

Disease

7	Atherosclerosis 07/2011 - 04/2003
2	Hemolysis 10/2017 - 04/2015
1	Starvation 11/2012
1	Necrosis 12/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2008
1	Infections 10/2008
1	Staphylococcal Infections 02/2008
1	Virus Diseases (Viral Diseases) 04/2006
1	Severe Dengue 04/2006

Drug/Important Bio-Agent (IBA)

3	Complement System Proteins (Complement)IBA 10/2017 - 08/2005
3	LDL Lipoproteins (beta Lipoproteins)IBA 07/2008 - 04/2004
2	Peptide Hydrolases (Proteases)FDA Link 04/2015 - 11/2004
2	oxidized low density lipoproteinIBA 07/2011 - 04/2003
2	Lipoproteins (Lipoprotein)IBA 12/2008 - 04/2004
2	C-Reactive ProteinIBA 08/2005 - 04/2004
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 10/2017
1	Purinergic Receptors (Receptors, Purine)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Adenosine Triphosphate (ATP)IBA 10/2017
1	Amino Acids FDA Link 11/2012
1	PotassiumIBA 11/2012
1	Nonesterified Fatty Acids (NEFA)IBA 07/2011
1	LipidsIBA 07/2011
1	NF-kappa B (NF-kB)IBA 12/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	Small Interfering RNA (siRNA)IBA 10/2008
1	Dynamins (Dynamin)IBA 10/2008
1	AntibodiesIBA 10/2008
1	CaveolinsIBA 10/2008
1	TetraspaninsIBA 10/2008
1	ClathrinIBA 10/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2008
1	ApoproteinsIBA 07/2008
1	ClusterinIBA 07/2008
1	InterferonsIBA 02/2008
1	staphylococcal alpha-toxinIBA 02/2008
1	Viral ProteinsIBA 04/2006
1	Apolipoproteins E (ApoE)IBA 08/2005
1	ApolipoproteinsIBA 08/2005
1	Matrix Metalloproteinases (MMPs)IBA 11/2004
1	PlasminogenIBA 11/2004
1	Fibrinolysin FDA Link 11/2004
1	low density lipoprotein inhibitorIBA 04/2004
1	CholesterolIBA 04/2004
1	Cathepsin HIBA 04/2003